| Chylomicronaemia—current diagnosis and future therapies AJ Brahm, RA Hegele Nature Reviews Endocrinology 11 (6), 352-362, 2015 | 329 | 2015 |
| The complex molecular genetics of familial hypercholesterolaemia AJ Berberich, RA Hegele Nature Reviews Cardiology 16 (1), 9-20, 2019 | 272 | 2019 |
| A modern approach to dyslipidemia AJ Berberich, RA Hegele Endocrine reviews 43 (4), 611-653, 2022 | 203 | 2022 |
| Hypertriglyceridemia A Brahm, RA Hegele Nutrients 5 (3), 981-1001, 2013 | 172 | 2013 |
| Clinical and biochemical features of different molecular etiologies of familial chylomicronemia RA Hegele, AJ Berberich, MR Ban, J Wang, A Digenio, VJ Alexander, ... Journal of clinical lipidology 12 (4), 920-927. e4, 2018 | 128 | 2018 |
| Combined hyperlipidemia: familial but not (usually) monogenic AJ Brahm, RA Hegele Current opinion in lipidology 27 (2), 131-140, 2016 | 84 | 2016 |
| Conservative management in hypertriglyceridemia‐associated pancreatitis AJ Berberich, A Ziada, GY Zou, RA Hegele Journal of internal medicine 286 (6), 644-650, 2019 | 68 | 2019 |
| Lomitapide for the treatment of hypercholesterolemia AJ Berberich, RA Hegele Expert opinion on pharmacotherapy 18 (12), 1261-1268, 2017 | 65 | 2017 |
| The role of genetic testing in dyslipidaemia AJ Berberich, RA Hegele Pathology 51 (2), 184-192, 2019 | 56 | 2019 |
| Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia JS Dron, J Wang, AJ Berberich, MA Iacocca, H Cao, P Yang, J Knoll, ... Journal of Lipid Research 59 (8), 1529-1535, 2018 | 31 | 2018 |
| Whole genome sequencing in the clinic: empowerment or too much information? AJ Berberich, R Ho, RA Hegele Cmaj 190 (5), E124-E125, 2018 | 30 | 2018 |
| Genetic confirmation rate in clinically suspected maturity-onset diabetes of the young AJ Brahm, G Wang, J Wang, AD McIntyre, H Cao, MR Ban, RA Hegele Canadian Journal of Diabetes 40 (6), 555-560, 2016 | 26 | 2016 |
| Lomitapide for the treatment of hypertriglyceridemia AJ Brahm, RA Hegele Expert Opinion on Investigational Drugs 25 (12), 1457-1463, 2016 | 25 | 2016 |
| Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia PK Gill, JS Dron, AJ Berberich, J Wang, AD McIntyre, H Cao, RA Hegele Journal of clinical lipidology 15 (1), 79-87, 2021 | 23 | 2021 |
| Dyslipidemias: pathophysiology, evaluation and management A Garg Springer, 2015 | 18 | 2015 |
| Incidence, predictors and patterns of care of patients with very severe hypertriglyceridemia in Ontario, Canada: a population-based cohort study AJ Berberich, AM Ouédraogo, SZ Shariff, RA Hegele, KK Clemens Lipids in Health and Disease 20, 1-11, 2021 | 17 | 2021 |
| Lipid effects of glucagon-like peptide 1 receptor analogs AJ Berberich, RA Hegele Current Opinion in Lipidology 32 (3), 191-199, 2021 | 15 | 2021 |
| Copy Number Variation in GCK in Patients With Maturity-Onset Diabetes of the Young AJ Berberich, C Huot, H Cao, AD McIntyre, JF Robinson, J Wang, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3428-3436, 2019 | 15 | 2019 |
| Adrenal Cushing syndrome diagnosed during pregnancy: successful medical management with metyrapone A Azzola, G Eastabrook, D Matsui, A Berberich, RG Tirona, D Gray, ... Journal of the Endocrine Society 5 (1), bvaa167, 2021 | 11 | 2021 |
| Nutraceuticals in endocrine disorders AJ Berberich, RA Hegele Nature Reviews Endocrinology 14 (2), 68-70, 2018 | 8 | 2018 |
